COVID-19 Impact on Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Eculizumab
  • 1.4.3 Methylprednisolone
  • 1.4.4 Azathioprine
  • 1.4.5 Mycophenolate Mofetil
  • 1.4.6 Rituximab
• 1.5 Market by Application
  • 1.5.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Devic’s Syndrome (Neuromyelitis Optica) Treatment Industry
    • 1.6.1.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Devic’s Syndrome (Neuromyelitis Optica) Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Devic’s Syndrome (Neuromyelitis Optica) Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Perspective (2015-2026)
• 2.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Growth Trends by Regions
  • 2.2.1 Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Devic’s Syndrome (Neuromyelitis Optica) Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Devic’s Syndrome (Neuromyelitis Optica) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Devic’s Syndrome (Neuromyelitis Optica) Treatment Players by Market Size
  • 3.1.1 Global Top Devic’s Syndrome (Neuromyelitis Optica) Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Concentration Ratio
  • 3.2.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Devic’s Syndrome (Neuromyelitis Optica) Treatment Revenue in 2019
• 3.3 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players Head office and Area Served
• 3.4 Key Players Devic’s Syndrome (Neuromyelitis Optica) Treatment Product Solution and Service
• 3.5 Date of Enter into Devic’s Syndrome (Neuromyelitis Optica) Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Forecasted Market Size by Type (2021-2026)

5 Devic’s Syndrome (Neuromyelitis Optica) Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)
• 5.2 Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 6.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in North America (2019-2020)
• 6.3 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 6.4 North America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 7.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 7.4 Europe Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 8.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in China (2019-2020)
• 8.3 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 8.4 China Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 9.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 9.4 Japan Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 10.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 11.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in India (2019-2020)
• 11.3 India Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 11.4 India Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size (2015-2020)
• 12.2 Devic’s Syndrome (Neuromyelitis Optica) Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Alexion Pharmaceuticals, Inc.
  • 13.1.1 Alexion Pharmaceuticals, Inc. Company Details
  • 13.1.2 Alexion Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.1.3 Alexion Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.1.4 Alexion Pharmaceuticals, Inc. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020))
  • 13.1.5 Alexion Pharmaceuticals, Inc. Recent Development
• 13.2 Teva Pharmaceuticals
  • 13.2.1 Teva Pharmaceuticals Company Details
  • 13.2.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  • 13.2.3 Teva Pharmaceuticals Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.2.4 Teva Pharmaceuticals Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.2.5 Teva Pharmaceuticals Recent Development
• 13.3 Fresenius Kabi AG
  • 13.3.1 Fresenius Kabi AG Company Details
  • 13.3.2 Fresenius Kabi AG Business Overview and Its Total Revenue
  • 13.3.3 Fresenius Kabi AG Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.3.4 Fresenius Kabi AG Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.3.5 Fresenius Kabi AG Recent Development
• 13.4 Pharmacia & Upjohn (a subsidary of Pfizer)
  • 13.4.1 Pharmacia & Upjohn (a subsidary of Pfizer) Company Details
  • 13.4.2 Pharmacia & Upjohn (a subsidary of Pfizer) Business Overview and Its Total Revenue
  • 13.4.3 Pharmacia & Upjohn (a subsidary of Pfizer) Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.4.4 Pharmacia & Upjohn (a subsidary of Pfizer) Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.4.5 Pharmacia & Upjohn (a subsidary of Pfizer) Recent Development
• 13.5 Lupin Ltd.
  • 13.5.1 Lupin Ltd. Company Details
  • 13.5.2 Lupin Ltd. Business Overview and Its Total Revenue
  • 13.5.3 Lupin Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.5.4 Lupin Ltd. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.5.5 Lupin Ltd. Recent Development
• 13.6 Sagent Pharmaceuticals, Inc.
  • 13.6.1 Sagent Pharmaceuticals, Inc. Company Details
  • 13.6.2 Sagent Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.6.3 Sagent Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.6.4 Sagent Pharmaceuticals, Inc. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.6.5 Sagent Pharmaceuticals, Inc. Recent Development
• 13.7 Zydus Pharmaceuticals, Inc.
  • 13.7.1 Zydus Pharmaceuticals, Inc. Company Details
  • 13.7.2 Zydus Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.7.3 Zydus Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.7.4 Zydus Pharmaceuticals, Inc. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.7.5 Zydus Pharmaceuticals, Inc. Recent Development
• 13.8 Sandoz Inc. (Novartis)
  • 13.8.1 Sandoz Inc. (Novartis) Company Details
  • 13.8.2 Sandoz Inc. (Novartis) Business Overview and Its Total Revenue
  • 13.8.3 Sandoz Inc. (Novartis) Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.8.4 Sandoz Inc. (Novartis) Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.8.5 Sandoz Inc. (Novartis) Recent Development
• 13.9 Alkem Laboratories Ltd.
  • 13.9.1 Alkem Laboratories Ltd. Company Details
  • 13.9.2 Alkem Laboratories Ltd. Business Overview and Its Total Revenue
  • 13.9.3 Alkem Laboratories Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.9.4 Alkem Laboratories Ltd. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.9.5 Alkem Laboratories Ltd. Recent Development
• 13.10 Mylan Pharmaceuticals, Inc.
  • 13.10.1 Mylan Pharmaceuticals, Inc. Company Details
  • 13.10.2 Mylan Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.10.3 Mylan Pharmaceuticals, Inc. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 13.10.4 Mylan Pharmaceuticals, Inc. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 13.10.5 Mylan Pharmaceuticals, Inc. Recent Development
• 13.11 Hoffmann-La Roche/ Chugai Pharmaceutical
  • 10.11.1 Hoffmann-La Roche/ Chugai Pharmaceutical Company Details
  • 10.11.2 Hoffmann-La Roche/ Chugai Pharmaceutical Business Overview and Its Total Revenue
  • 10.11.3 Hoffmann-La Roche/ Chugai Pharmaceutical Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 10.11.4 Hoffmann-La Roche/ Chugai Pharmaceutical Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 10.11.5 Hoffmann-La Roche/ Chugai Pharmaceutical Recent Development
• 13.12 MedImmune LLC
  • 10.12.1 MedImmune LLC Company Details
  • 10.12.2 MedImmune LLC Business Overview and Its Total Revenue
  • 10.12.3 MedImmune LLC Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 10.12.4 MedImmune LLC Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 10.12.5 MedImmune LLC Recent Development
• 13.13 RemeGen, Ltd.
  • 10.13.1 RemeGen, Ltd. Company Details
  • 10.13.2 RemeGen, Ltd. Business Overview and Its Total Revenue
  • 10.13.3 RemeGen, Ltd. Devic’s Syndrome (Neuromyelitis Optica) Treatment Introduction
  • 10.13.4 RemeGen, Ltd. Revenue in Devic’s Syndrome (Neuromyelitis Optica) Treatment Business (2015-2020)
  • 10.13.5 RemeGen, Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer